Introduction {#Sec1}
============

Hydroxychloroquine is an antimalarial medication that can cause hyperpigmentation of nails, mucosa, and skin \[[@CR1]--[@CR5]\]. Retrospective studies cite the incidence of drug-related hyperpigmentation from hydroxychloroquine to be as high as 33% of individuals \[[@CR6]\].

Elder abuse is a cause of significant morbidity and mortality in older individuals \[[@CR7]--[@CR9]\]. Elder abuse and neglect is a significant problem in seniors and the annual reported incidence ranges from 2% to 10% \[[@CR9], [@CR10]\]; yet, it is suspected that only 1 in 5 cases is actually reported \[[@CR9]\]. Indeed, older individuals who are the victims of elder abuse can present with bruising and resolving ecchymoses.

In the present paper, an older woman with hydroxychloroquine-associated cutaneous pigmentation that was misinterpreted as elder abuse is described, mucosal and skin manifestations of elder abuse are reviewed, and cutaneous mimickers of elder abuse are summarized.

Case Report {#Sec2}
===========

A 66-year-old white woman presented for an evaluation of her skin. Informed consent was obtained from the patient for being included in the study. Additional informed consent was obtained from all patients for which identifying information is included in this article. The patient's past medical history was significant for systemic lupus erythematosus and myasthenia gravis. Since 1980, the patient has been treated with hydroxychloroquine at a daily dose of 400 mg.

There was diffuse hyperpigmentation. The patient's forehead, face, neck, v-area of the upper central chest, and upper back were black (Figs. [1](#Fig1){ref-type="fig"}, [2](#Fig2){ref-type="fig"}), and her right upper chest was blue (Figs. [1](#Fig1){ref-type="fig"}, [3](#Fig3){ref-type="fig"}). Hyperpigmentation was absent from her oral mucosa and nails.Fig. 1Diffuse black hyperpigmentation of the forehead, face, neck, and v-area of the upper central chest of a woman with systemic lupus erythematosus who has been receiving hydroxychloroquine for more than 30 years. There is also blue dyschromia of the upper right chest. The infusion port on her left chest is for plasmapheresis treatment of her myasthenia gravisFig. 2Diffuse hydroxychloroquine-associated black hyperpigmentation involving the entire upper back, originally misinterpreted as elder abuse, in a 66-year-old woman with systemic lupus erythematosusFig. 3A closer view of her upper right chest shows biopsy-confirmed hydroxychloroquine-associated blue pigmentation of the skin

Five years earlier, the patient had visited a new clinician on a Friday afternoon. The patient's clinician misinterpreted her black and blue dyschromia to be trauma-induced and had notified Adult Protective Services. The following Monday morning, a worker from the agency was at her home to investigate the family for elder abuse. Eventually the situation was resolved and the family was cleared of all suspicion of elder abuse.

During her current cutaneous evaluation, a skin biopsy from the area of blue dyschromia on the patient's right upper chest was performed. Microscopic examination showed both intracellular and extracellular yellow-to-brown granules scattered throughout the reticular dermis. Pigmented granules were seen between the collagen bundles with some accentuation around eccrine glands. The granules stained positively for both Fontana Masson and Perl's stains.

Correlation of the patient's medical history, clinical presentation, and pathology findings confirmed the diagnosis of hydroxychloroquine-induced hyperpigmentation.

Discussion {#Sec3}
==========

Hydroxychloroquine, which has a 4-aminoquinoline nucleus, is used in the management of malaria, rheumatologic disorders, and dermatologic conditions, such as lupus erythematosus, polymorphous light eruption, and porphyria cutanea tarda \[[@CR1], [@CR5]\]. Most commonly, its use can result in hyperpigmentation of the forehead, hard palate, forearms, and shins \[[@CR2], [@CR3]\]; it can also cause pigmentation that appears on the cheek mucosa and nails \[[@CR6], [@CR11]\]. The development of hydroxychloroquine-associated cutaneous dyschromia is not so rare and can present as black, blue-gray or blue discoloration in photodistributed areas or skin sites protected from the sun \[[@CR6]\].

Microscopic examination of hydroxychloroquine hyperpigmentation shows yellow-brown, non-refractile, coarsely granular pigmented deposits, amongst the collagen fibers in the superficial dermis; they are also located not only within macrophages but also extracellularly \[[@CR12]--[@CR14]\]. The granules stain positive for either melanin \[[@CR15]\] or both melanin and hemosiderin \[[@CR13], [@CR16]\]. It has been postulated that this accumulation of melanin, hemosiderin, or both results in the pigmentation observed clinically \[[@CR6], [@CR12]\]. In addition, it has also been hypothesized that there is a relationship between the development of pigment changes and the length of use of hydroxychloroquine \[[@CR6]\].

Hydroxychloroquine pigmentation can occur within 1 year after starting therapy \[[@CR4], [@CR12], [@CR13], [@CR17]\]. The skin discoloration has no systemic adverse sequelae. After discontinuation of the drug, the hydroxychloroquine-associated pigmentation slowly fades. The reported time for spontaneous regression of the hyperpigmentation ranges from 2 to 6 months \[[@CR6], [@CR12]\]; however, persistent cutaneous hyperpigmentation even 1 year after discontinuation of therapy has been observed \[[@CR18]\].

The present patient had black hydroxychloroquine-associated hyperpigmentation on her face, v-area of her upper central chest, and other sites that were exposed to the sun. In addition, the patient had drug-related blue patches of dyschromia on sun protected areas, such as the right side of her chest, above her breast. Microscopic examination was significant for not only intracellular hydroxychloroquine granules but also extracellular granules; this finding correlates with the patient's clinical history of still receiving hydroxychloroquine; hence, new particles continue to be deposited in the dermis and have not all been engulfed by macrophages.

Elder abuse---also referred to as abuse of older adults and mistreatment of seniors---is: (1) any intentional action (by either a person who has a trusted relationship with the older individual or a caregiver) that results in either serious risk of harm or actual injury to a vulnerable elder, or (2) failure of a caregiver to either protect the older adult from harm or satisfy the senior's basic needs. Several types of elder abuse exist: abandonment, emotional or psychological abuse, financial or material exploitation, neglect, physical abuse, resident-to-resident aggression, self-neglect, and sexual abuse. Most commonly, the perpetrator of elder abuse is a family member \[[@CR6]--[@CR8]\].

Cutaneous manifestations of elder abuse include signs of physical abuse, self-neglect, and sexual abuse (Table [1](#Tab1){ref-type="table"}) \[[@CR10], [@CR19]\]. However, mucosal and skin lesions of systemic conditions or accidental external injury can mimic elder abuse (Table [2](#Tab2){ref-type="table"}) \[[@CR10], [@CR19]\]. Chang et al. \[[@CR19]\] and Palmer et al. \[[@CR10]\] presented brief reports with accompanying illustrations of elder abuse mimickers: (1) the chronically sun-damaged extensor surface of an elderly woman's forearm with suspected traumatic purpura, which actually represented Bateman's purpura (also referred to as senile purpura or solar purpura) following minor incidental bumping of the skin during routine activity; (2) digitate purpura on the abdomen of an older man suspicious for a trauma-inflicted etiology that actually appeared following deep palpation by the physician in the setting of the patient's hepatic coagulopathy; and (3) purpura in the inguinal folds of an older man mistaken by emergency providers to represent blunt trauma with intraabdominal hemorrhage but actually showed leukocytoclastic vasculitis on skin biopsy.Table 1Cutaneous manifestations of elder abusePhysical abuse Abrasions and lacerations Alopecia (traumatic) Bruising and ecchymoses BurnsSelf-neglect Hair care-poor Nail care-poor Perineal dermatitis  Irritant dermatitis from prolonged exposure to urine or fecesUlcers Basal cell carcinoma (advanced) Pressure-induced (over bony prominences) Squamous cell carcinoma (advanced)Vitamin deficiency Acral dermatitis (zinc deficiency) Cheilitis (vitamin B12, folic acid, or iron deficiency) Glossitis (vitamin B12, folic acid, or iron deficiency) Periorificial lesions (biotin or zinc deficiency) Photosensitivity (vitamin B3 or vitamin B6-pellagra deficiency) Phrynoderma (keratosis pilaris-like lesions from vitamin A deficiency) Purpura or petechiae (vitamin C if perifollicular or vitamin K deficiency)Sexual abuse Sexually transmitted skin disease lesions^a^  Blisters (herpes simplex virus infection)  Candidiasis (possible human immunodeficiency virus-associated)  Condyloma acuminata (human papillomavirus infection)  Condyloma lata (secondary syphilis infection)  Erosions and ulcers (chancroid or secondary syphilis infection) Traumatic injuries  Abrasions  Bruising^a^The observation of these lesions is suspicious for elder abuse especially when they occur in patients who do not have decision-making capacity and who are, therefore, not able to consent to sexual activityTable 2Mimickers of physical abuse and sexual abuse in eldersPhysical abuse Alopecia  Patients with age-related patterned (frontotemporal and vertex) hair loss Blisters and bullae  Patients with primary autoimmune bullous diseases Bruises on bony prominences, buttocks, dorsal feet, genitals, and inner thighs  Patients with limited mobility Bruises usually on extensor extremities  Accidental injury in patients with medication-associated coagulopathy Hyperpigmentation mimicking bruises  Patients receiving certain systemic medications:   Amiodarone, antimalarials, minocycline, or phenothiazines Purpura: non-specific pattern  Corticosteroid-associated:   Sun exposed areas after mild trauma in patients on systemic corticosteroids   Sites of topical corticosteroid application  Vasculitis and vasculopathy Purpura in shape of finger indentations around extremities  Caregiver's efforts to aid patients who are immobile  Normal capillary fragility  Patients with conditions associated with coagulopathy Purpura on extensor surfaces of sun exposed forearms  Bateman's purpura (also referred to as senile purpura or solar purpura)^a^ Rash in stocking and glove distribution mimicking immersion burn  Contact dermatitis from socks, footwear, or mittens and gloves^b^Sexual abuse Anal fissures and excoriation (mimicking trauma)  Constipation induced  Inflammatory bowel disease Bleeding and bruising of the genitalia  Catheterization difficulty Genital erosions and ulcers  Behcet disease  Lichen planus (erosive mucosal)  Squamous cell carcinoma Genital excoriations and bleeding  Decreased estrogen levels in postmenopausal women Penile annular confluent erythema and subsequent hyperpigmentation mimicking trauma  Fixed drug eruption (to drugs such as barbiturates, tetracycline, or stool softeners) Perineal maceration and irritation  Incontinence of stool and urine Perineum with lesions morphologically similar to healed trauma-induced scars  Lichen sclerosus et atrophicus^a^Dermal capillaries are unsupported and susceptible to injury because of degeneration of extracellular matrix components^b^The condition is usually pruritic instead of painful

The diffuse hyperpigmentation secondary to hydroxychloroquine treatment of the patient in the present report was misinterpreted as elder abuse and the family was visited by Adult Protective Services. Recently, True et al. \[[@CR20]\] described a patient who had rheumatoid arthritis for which hydroxychloroquine was given for many years with good clinical results; subsequently, large areas of hyperpigmentation developed over all extremities, the torso, and the hairline. The patient's hyperpigmentation was so pronounced that on one occasion, similar to the present patient, health care personnel filed a report of elder abuse \[[@CR20]\].

A thorough history is paramount in excluding other conditions that can mimic elder abuse. In addition, laboratory studies may be helpful to establish the diagnosis of a medical infirmity masquerading as elder abuse. Finally, similar to the present patient, a skin biopsy may be essential to exclude elder abuse and establish the correct diagnosis.

Conclusion {#Sec4}
==========

Antimalarials, such as hydroxychloroquine, are still a mainstay therapy in the management of patients with lupus erythematosus and rheumatoid arthritis. Physical abuse of elders can be suspected based upon associated cutaneous findings, such as patterned shape or distribution of lesions, various stages of healing lesions, signs of blunt trauma, bilateral or parallel injuries on extremities, and alopecia with irregular patches of hair loss and hairs of varying lengths or many short hairs. However, hyperpigmentation from either accidental external trauma, cutaneous conditions, mucocutaneous manifestations of medications, or systemic disorders can mimic the morphologic features of elder abuse (Table [3](#Tab3){ref-type="table"}) \[[@CR1]--[@CR4], [@CR21]--[@CR39]\]. Hydroxychloroquine-associated hyperpigmentation in an elderly woman was clinically misinterpreted as elder abuse resulting in notification of Adult Protective Services by the clinician; skin biopsy subsequently confirmed the etiology of her diffuse black and blue dyschromia. When the diagnosis of elder abuse is entertained, a complete medical history---including medications being taken by the patient---should be conducted. Appropriate laboratory studies, including skin biopsy, may be helpful in establishing or excluding the diagnosis of elder abuse.Table 3Causes of hyperpigmentation mimicking elder abuseAccidental external traumaCutaneous conditions Benign pigmented purpuric eruption Erythema dyschromicum perstans \[[@CR21]\] Lichen amyloidosis Macular amyloidosis Postinflammatory hyperpigmentation \[[@CR22]\]Medication-induced Amiodarone \[[@CR23]\] Antimalarials \[[@CR1], [@CR3]\] Bismuth \[[@CR2]\] Clofazimine \[[@CR2]\] Gold \[[@CR24], [@CR25]\] Mercury \[[@CR2], [@CR26]\] Methylene blue \[[@CR27]\] Minocycline \[[@CR28], [@CR29]\] Phenothiazines \[[@CR4], [@CR30]\] Phenol \[[@CR31]\] Silver \[[@CR32]\]Systemic disorders Addison's disease \[[@CR32]\] Alkaptonuria \[[@CR33]\] Blue toe syndrome \[[@CR34]\] DRESS syndrome (post baclofen, piracetam, and mitoxantrone) \[[@CR35]\] Hemochromatosis \[[@CR36]\] Melanosis cutis (diffuse) \[[@CR37]\] Ochronosis (endogenous) \[[@CR38]\] POEMS syndrome (associated with Castleman's disease) \[[@CR39]\]*DRESS* drug rash with eosinophilia and systemic signs, *POEMS* polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes
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